Key Points
- GTCR Investment XI LLC, a Sotera Health director, sold a total of 18.48 million shares across Nov. 10 and Dec. 3 (12.0M at $15.65 and 6.48M at $16.33) for roughly $293.6 million in proceeds, trimming its position to 22,735,301 shares (a 22.18% decrease).
- Sotera Health shares trade around $16.75 with a market cap of $4.76 billion; the company set FY2025 EPS guidance of 0.81–0.86 and analysts have an average price target of $17.80 with mixed Buy/Hold ratings.
Sotera Health Company (NASDAQ:SHC - Get Free Report) Director Gtcr Investment Xi Llc sold 6,480,000 shares of Sotera Health stock in a transaction dated Wednesday, December 3rd. The stock was sold at an average price of $16.33, for a total transaction of $105,818,400.00. Following the completion of the transaction, the director owned 22,735,301 shares of the company's stock, valued at $371,267,465.33. The trade was a 22.18% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
Gtcr Investment Xi Llc also recently made the following trade(s):
- On Monday, November 10th, Gtcr Investment Xi Llc sold 12,000,000 shares of Sotera Health stock. The shares were sold at an average price of $15.65, for a total transaction of $187,800,000.00.
Sotera Health Stock Up 1.1%
Shares of NASDAQ SHC opened at $16.75 on Friday. The business has a 50-day moving average of $16.31 and a 200-day moving average of $14.35. The firm has a market capitalization of $4.76 billion, a price-to-earnings ratio of 88.16 and a beta of 1.81. The company has a current ratio of 2.38, a quick ratio of 2.18 and a debt-to-equity ratio of 4.04. Sotera Health Company has a 12 month low of $9.53 and a 12 month high of $17.78.
Sotera Health (NASDAQ:SHC - Get Free Report) last announced its quarterly earnings data on Tuesday, November 4th. The company reported $0.26 earnings per share for the quarter, beating analysts' consensus estimates of $0.22 by $0.04. The company had revenue of $311.31 million for the quarter, compared to analysts' expectations of $303.63 million. Sotera Health had a return on equity of 43.69% and a net margin of 4.82%.Sotera Health has set its FY 2025 guidance at 0.810-0.860 EPS. Sell-side analysts expect that Sotera Health Company will post 0.61 earnings per share for the current fiscal year.
Analysts Set New Price Targets
Several analysts recently weighed in on SHC shares. Barclays upped their price target on Sotera Health from $19.00 to $20.00 and gave the stock an "overweight" rating in a research note on Wednesday, November 5th. Piper Sandler boosted their target price on shares of Sotera Health from $15.00 to $17.00 and gave the company a "neutral" rating in a research report on Wednesday, November 5th. BMO Capital Markets started coverage on Sotera Health in a research note on Thursday, November 13th. They issued an "outperform" rating and a $19.00 price objective on the stock. JPMorgan Chase & Co. upped their target price on shares of Sotera Health from $14.00 to $16.00 and gave the stock a "neutral" rating in a report on Wednesday, November 5th. Finally, Weiss Ratings reiterated a "hold (c-)" rating on shares of Sotera Health in a research report on Tuesday. Three analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, Sotera Health presently has an average rating of "Moderate Buy" and an average price target of $17.80.
Check Out Our Latest Analysis on Sotera Health
Institutional Investors Weigh In On Sotera Health
A number of institutional investors have recently added to or reduced their stakes in the stock. Versant Capital Management Inc grew its holdings in Sotera Health by 117.6% in the third quarter. Versant Capital Management Inc now owns 2,535 shares of the company's stock worth $40,000 after purchasing an additional 1,370 shares during the last quarter. UMB Bank n.a. boosted its holdings in Sotera Health by 112.8% in the second quarter. UMB Bank n.a. now owns 2,635 shares of the company's stock worth $29,000 after acquiring an additional 1,397 shares in the last quarter. Caitong International Asset Management Co. Ltd boosted its holdings in Sotera Health by 3,690.1% in the first quarter. Caitong International Asset Management Co. Ltd now owns 2,691 shares of the company's stock worth $31,000 after acquiring an additional 2,620 shares in the last quarter. EverSource Wealth Advisors LLC grew its stake in shares of Sotera Health by 831.4% during the second quarter. EverSource Wealth Advisors LLC now owns 3,288 shares of the company's stock worth $37,000 after acquiring an additional 2,935 shares during the last quarter. Finally, Parallel Advisors LLC increased its holdings in shares of Sotera Health by 124.0% during the second quarter. Parallel Advisors LLC now owns 3,340 shares of the company's stock valued at $37,000 after acquiring an additional 1,849 shares in the last quarter. Institutional investors own 91.03% of the company's stock.
Sotera Health Company Profile
(
Get Free Report)
Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
